tiprankstipranks
Trending News
More News >
Pharming Group N.V. (DE:PHGN)
XETRA:PHGN
Germany Market

Pharming Group (PHGN) Income Statement

Compare
4 Followers

Pharming Group Income Statement

Last quarter (Q4 2025), Pharming Group's total revenue was €91.50M, a decrease of -1.26% from the same quarter last year. In Q4, Pharming Group's net income was €4.55M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 333.28M€ 286.89M€ 245.32M€ 205.62M€ 189.85M
Gross Profit
€ 292.97M€ 231.82M€ 220.10M€ 188.06M€ 169.67M
Operating Expenses
€ 275.85M€ 235.21M€ 225.49M€ 169.83M€ 156.72M
Depreciation and Amortization
€ 9.94M€ 10.21M€ 15.93M€ 13.19M€ 19.61M
EBITDA
€ 27.05M€ 13.18M€ 9.88M€ 33.53M€ 48.78M
Operating Income
€ 17.11M€ -3.39M€ -4.88M€ 18.23M€ 27.84M
Other Income/Expenses
€ -5.73M€ -4.46M€ -7.13M€ -3.25M€ -4.76M
Pretax Income
€ 11.38M€ -7.85M€ -12.01M€ 14.99M€ 22.03M
Net Income
€ 2.53M€ -10.64M€ -10.55M€ 13.67M€ 16.00M
Per Share Metrics
Basic EPS
€ <0.01€ -0.02€ -0.01€ 0.02€ 0.02
Diluted EPS
€ <0.01€ -0.02€ -0.01€ 0.02€ 0.02
Weighted Average Shares Outstanding
721.77M 689.19M 821.28M 883.93M 876.44M
Weighted Average Shares Outstanding (Diluted)
721.77M 689.19M 843.25M 883.93M 876.44M
Currency in EUR

Pharming Group Earnings and Revenue History